Insider Trading & Ownership of IAN T. CLARK

Location: Palo Alto, CA
Summary: The estimated net worth of IAN T. CLARK is at least $2,748,847 dollars as of 23 Dec 2025. IAN T. CLARK is the Director of Guardant Health, Inc. and owns shares of Guardant Health, Inc. (GH) stock worth about $1.29M. IAN T. CLARK is the Director of GoodRx Holdings, Inc. and owns shares of GoodRx Holdings, Inc. (GDRX) stock worth about $880.4K. IAN T. CLARK is the Director of BIOMARIN PHARMACEUTICAL INC and owns shares of BIOMARIN PHARMACEUTICAL INC (BMRN) stock worth about $401.9K. IAN T. CLARK is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $141.7K. IAN T. CLARK is the Director of Kyverna Therapeutics, Inc. and owns shares of Kyverna Therapeutics, Inc. (KYTX) stock worth about $35.1K.
Signature: /s/ Shane Kovacs, Attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when IAN T. CLARK files a new Insider Trading report.

Ownership of IAN T. CLARK

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
GH	Guardant Health, Inc.	Director	$1,289,768	-$3,389,636	-72%	05 Dec 2025
GDRX	GoodRx Holdings, Inc.	Director	$880,392			08 Jul 2025
BMRN	BIOMARIN PHARMACEUTICAL INC	Director	$401,870			01 Aug 2025
AGIO	AGIOS PHARMACEUTICALS, INC.	Director	$141,720			20 May 2022
KYTX	Kyverna Therapeutics, Inc.	Director	$35,097			29 May 2025
OLMA	Olema Pharmaceuticals, Inc.	Director	$0	-$7,873,109	-100%	19 Dec 2025
TECX	Tectonic Therapeutic, Inc.	Director				06 Jun 2023
CRVS	Corvus Pharmaceuticals, Inc.	Director				12 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.